Global Equine Pharmaceuticals and Supplements Market Insights and Forecast to 2027

Report ID: 854916 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Equine Pharmaceuticals and Supplements Product Introduction
    1.2 Market by Type
        1.2.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type
        1.4.2 Pharmaceuticals
        1.4.3 Supplements
    1.3 Market by Application
        1.3.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application
        1.3.2 Thoroughbred Horse
        1.3.3 Other Types of Horses
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts 2016-2027
    2.2 Global Equine Pharmaceuticals and Supplements Revenue Estimates and Forecasts 2016-2027
    2.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Equine Pharmaceuticals and Supplements Regions by Sales
        2.4.1 Global Top Equine Pharmaceuticals and Supplements Regions by Sales (2016-2021)
        2.4.2 Global Top Equine Pharmaceuticals and Supplements Regions by Sales (2022-2027)
    2.5 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue
        2.5.1 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue (2016-2021)
        2.5.2 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers
        3.1.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Equine Pharmaceuticals and Supplements Sales in 2020
    3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers
        3.2.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Equine Pharmaceuticals and Supplements Revenue in 2020
    3.3 Global Equine Pharmaceuticals and Supplements Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Equine Pharmaceuticals and Supplements Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Equine Pharmaceuticals and Supplements Sales by Type
        4.1.1 Global Equine Pharmaceuticals and Supplements Historical Sales by Type (2016-2021)
        4.1.2 Global Equine Pharmaceuticals and Supplements Forecasted Sales by Type (2022-2027)
        4.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    4.2 Global Equine Pharmaceuticals and Supplements Revenue by Type
        4.2.1 Global Equine Pharmaceuticals and Supplements Historical Revenue by Type (2016-2021)
        4.2.2 Global Equine Pharmaceuticals and Supplements Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    4.3 Global Equine Pharmaceuticals and Supplements Price by Type
        4.3.1 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2021)
        4.3.2 Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Equine Pharmaceuticals and Supplements Sales by Application
        5.1.1 Global Equine Pharmaceuticals and Supplements Historical Sales by Application (2016-2021)
        5.1.2 Global Equine Pharmaceuticals and Supplements Forecasted Sales by Application (2022-2027)
        5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    5.2 Global Equine Pharmaceuticals and Supplements Revenue by Application
        5.2.1 Global Equine Pharmaceuticals and Supplements Historical Revenue by Application (2016-2021)
        5.2.2 Global Equine Pharmaceuticals and Supplements Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    5.3 Global Equine Pharmaceuticals and Supplements Price by Application
        5.3.1 Global Equine Pharmaceuticals and Supplements Price by Application (2016-2021)
        5.3.2 Global Equine Pharmaceuticals and Supplements Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Equine Pharmaceuticals and Supplements Market Size by Type
        6.1.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2027)
        6.1.2 North America Equine Pharmaceuticals and Supplements Revenue by Type (2016-2027)
    6.2 North America Equine Pharmaceuticals and Supplements Market Size by Application
        6.2.1 North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2027)
        6.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Application (2016-2027)
    6.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
        6.3.1 North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
        6.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Equine Pharmaceuticals and Supplements Market Size by Type
        7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2017-2027)
        7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Type (2017-2027)
    7.2 Europe Equine Pharmaceuticals and Supplements Market Size by Application
        7.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Application (2017-2027)
        7.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Application (2017-2027)
    7.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
        7.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2017-2027)
        7.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Type
        8.1.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Type (2018-2027)
        8.1.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Type (2018-2027)
    8.2 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Application
        8.2.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Application (2018-2027)
        8.2.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Application (2018-2027)
    8.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region
        8.3.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2018-2027)
        8.3.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Type
        9.1.1 Latin America Equine Pharmaceuticals and Supplements Sales by Type (2019-2027)
        9.1.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2019-2027)
    9.2 Latin America Equine Pharmaceuticals and Supplements Market Size by Application
        9.2.1 Latin America Equine Pharmaceuticals and Supplements Sales by Application (2019-2027)
        9.2.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2019-2027)
    9.3 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
        9.3.1 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2019-2027)
        9.3.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Type
        6.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Type (2016-2027)
    6.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Application
        6.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Application (2016-2027)
    6.3 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country
        6.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Description
        11.1.5 Boehringer Ingelheim Related Developments
    11.2 Merck Animal Health
        11.2.1 Merck Animal Health Corporation Information
        11.2.2 Merck Animal Health Overview
        11.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Description
        11.2.5 Merck Animal Health Related Developments
    11.3 Zoetis
        11.3.1 Zoetis Corporation Information
        11.3.2 Zoetis Overview
        11.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Description
        11.3.5 Zoetis Related Developments
    11.4 Bayer Animal Health
        11.4.1 Bayer Animal Health Corporation Information
        11.4.2 Bayer Animal Health Overview
        11.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Description
        11.4.5 Bayer Animal Health Related Developments
    11.5 Elanco Animal Health
        11.5.1 Elanco Animal Health Corporation Information
        11.5.2 Elanco Animal Health Overview
        11.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Description
        11.5.5 Elanco Animal Health Related Developments
    11.6 Dechra Veterinary Products
        11.6.1 Dechra Veterinary Products Corporation Information
        11.6.2 Dechra Veterinary Products Overview
        11.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Description
        11.6.5 Dechra Veterinary Products Related Developments
    11.7 CEVA
        11.7.1 CEVA Corporation Information
        11.7.2 CEVA Overview
        11.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 CEVA Equine Pharmaceuticals and Supplements Product Description
        11.7.5 CEVA Related Developments
    11.8 Virbac
        11.8.1 Virbac Corporation Information
        11.8.2 Virbac Overview
        11.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Virbac Equine Pharmaceuticals and Supplements Product Description
        11.8.5 Virbac Related Developments
    11.9 Norbrook Equine
        11.9.1 Norbrook Equine Corporation Information
        11.9.2 Norbrook Equine Overview
        11.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Description
        11.9.5 Norbrook Equine Related Developments
    11.10 Kyoritsu Seiyaku
        11.10.1 Kyoritsu Seiyaku Corporation Information
        11.10.2 Kyoritsu Seiyaku Overview
        11.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Description
        11.10.5 Kyoritsu Seiyaku Related Developments
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Description
        11.1.5 Boehringer Ingelheim Related Developments
    11.12 Protexin Healthcare
        11.12.1 Protexin Healthcare Corporation Information
        11.12.2 Protexin Healthcare Overview
        11.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Protexin Healthcare Product Description
        11.12.5 Protexin Healthcare Related Developments
    11.13 Audevard
        11.13.1 Audevard Corporation Information
        11.13.2 Audevard Overview
        11.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Audevard Product Description
        11.13.5 Audevard Related Developments
    11.14 Ouro Fino Saude
        11.14.1 Ouro Fino Saude Corporation Information
        11.14.2 Ouro Fino Saude Overview
        11.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Ouro Fino Saude Product Description
        11.14.5 Ouro Fino Saude Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
    12.2 Equine Pharmaceuticals and Supplements Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Equine Pharmaceuticals and Supplements Production Mode & Process
    12.4 Equine Pharmaceuticals and Supplements Sales and Marketing
        12.4.1 Equine Pharmaceuticals and Supplements Sales Channels
        12.4.2 Equine Pharmaceuticals and Supplements Distributors
    12.5 Equine Pharmaceuticals and Supplements Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Equine Pharmaceuticals and Supplements Industry Trends
    13.2 Equine Pharmaceuticals and Supplements Market Drivers
    13.3 Equine Pharmaceuticals and Supplements Market Challenges
    13.4 Equine Pharmaceuticals and Supplements Market Restraints

14 Key Findings in The Global Equine Pharmaceuticals and Supplements Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Pharmaceuticals
    Table 3. Major Manufacturers of Supplements
    Table 4. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 5. Global Equine Pharmaceuticals and Supplements Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
    Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2021)
    Table 8. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
    Table 9. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2022-2027)
    Table 10. Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2021)
    Table 12. Global Equine Pharmaceuticals and Supplements Revenue by Region (2022-2027) & (US$ Million)
    Table 13. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2022-2027)
    Table 14. Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2021) & (K Units)
    Table 15. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturers (2016-2021)
    Table 16. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 17. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2016-2021)
    Table 18. Equine Pharmaceuticals and Supplements Price by Manufacturers 2016-2021 (USD/Unit)
    Table 19. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2020)
    Table 21. Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Equine Pharmaceuticals and Supplements Product Offered
    Table 23. Date of Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 26. Global Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 27. Global Equine Pharmaceuticals and Supplements Sales Share by Type (2016-2021)
    Table 28. Global Equine Pharmaceuticals and Supplements Sales Share by Type (2022-2027)
    Table 29. Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 30. Global Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 31. Global Equine Pharmaceuticals and Supplements Revenue Share by Type (2016-2021)
    Table 32. Global Equine Pharmaceuticals and Supplements Revenue Share by Type (2022-2027)
    Table 33. Equine Pharmaceuticals and Supplements Price by Type (2016-2021) & (USD/Unit)
    Table 34. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 35. Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 36. Global Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 37. Global Equine Pharmaceuticals and Supplements Sales Share by Application (2016-2021)
    Table 38. Global Equine Pharmaceuticals and Supplements Sales Share by Application (2022-2027)
    Table 39. Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 40. Global Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 41. Global Equine Pharmaceuticals and Supplements Revenue Share by Application (2016-2021)
    Table 42. Global Equine Pharmaceuticals and Supplements Revenue Share by Application (2022-2027)
    Table 43. Equine Pharmaceuticals and Supplements Price by Application (2016-2021) & (USD/Unit)
    Table 44. Global Equine Pharmaceuticals and Supplements Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 45. North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 46. North America Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 47. North America Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 48. North America Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 49. North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 50. North America Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 51. North America Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 52. North America Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 53. North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 54. North America Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 55. North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 56. North America Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 57. Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 58. Europe Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 59. Europe Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 60. Europe Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 61. Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 62. Europe Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 63. Europe Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 64. Europe Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 65. Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 66. Europe Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 67. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 68. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 69. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 70. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 71. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 72. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 73. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 74. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 75. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 77. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
    Table 78. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2022-2027) & (K Units)
    Table 79. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021) & (US$ Million)
    Table 80. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2022-2027) & (US$ Million)
    Table 81. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 82. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 83. Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 84. Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 85. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 86. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 87. Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 88. Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 89. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 90. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 91. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 92. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 93. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 94. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2022-2027) & (K Units)
    Table 95. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 96. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Type (2022-2027) & (US$ Million)
    Table 97. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 98. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2022-2027) & (K Units)
    Table 99. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 100. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Application (2022-2027) & (US$ Million)
    Table 101. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 102. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 103. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 104. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 105. Boehringer Ingelheim Corporation Information
    Table 106. Boehringer Ingelheim Description and Major Businesses
    Table 107. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 108. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
    Table 109. Boehringer Ingelheim Recent Developments
    Table 110. Merck Animal Health Corporation Information
    Table 111. Merck Animal Health Description and Major Businesses
    Table 112. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. Merck Animal Health Equine Pharmaceuticals and Supplements Product
    Table 114. Merck Animal Health Recent Developments
    Table 115. Zoetis Corporation Information
    Table 116. Zoetis Description and Major Businesses
    Table 117. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Zoetis Equine Pharmaceuticals and Supplements Product
    Table 119. Zoetis Recent Developments
    Table 120. Bayer Animal Health Corporation Information
    Table 121. Bayer Animal Health Description and Major Businesses
    Table 122. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
    Table 124. Bayer Animal Health Recent Developments
    Table 125. Elanco Animal Health Corporation Information
    Table 126. Elanco Animal Health Description and Major Businesses
    Table 127. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
    Table 129. Elanco Animal Health Recent Developments
    Table 130. Dechra Veterinary Products Corporation Information
    Table 131. Dechra Veterinary Products Description and Major Businesses
    Table 132. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
    Table 134. Dechra Veterinary Products Recent Developments
    Table 135. CEVA Corporation Information
    Table 136. CEVA Description and Major Businesses
    Table 137. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. CEVA Equine Pharmaceuticals and Supplements Product
    Table 139. CEVA Recent Developments
    Table 140. Virbac Corporation Information
    Table 141. Virbac Description and Major Businesses
    Table 142. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Virbac Equine Pharmaceuticals and Supplements Product
    Table 144. Virbac Recent Developments
    Table 145. Norbrook Equine Corporation Information
    Table 146. Norbrook Equine Description and Major Businesses
    Table 147. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 148. Norbrook Equine Equine Pharmaceuticals and Supplements Product
    Table 149. Norbrook Equine Recent Developments
    Table 150. Kyoritsu Seiyaku Corporation Information
    Table 151. Kyoritsu Seiyaku Description and Major Businesses
    Table 152. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 153. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
    Table 154. Kyoritsu Seiyaku Recent Developments
    Table 155. Vetoquinol Corporation Information
    Table 156. Vetoquinol Description and Major Businesses
    Table 157. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Vetoquinol Equine Pharmaceuticals and Supplements Product
    Table 159. Vetoquinol Recent Developments
    Table 160. Protexin Healthcare Corporation Information
    Table 161. Protexin Healthcare Description and Major Businesses
    Table 162. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
    Table 164. Protexin Healthcare Recent Developments
    Table 165. Audevard Corporation Information
    Table 166. Audevard Description and Major Businesses
    Table 167. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. Audevard Equine Pharmaceuticals and Supplements Product
    Table 169. Audevard Recent Developments
    Table 170. Ouro Fino Saude Corporation Information
    Table 171. Ouro Fino Saude Description and Major Businesses
    Table 172. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 173. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
    Table 174. Ouro Fino Saude Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Equine Pharmaceuticals and Supplements Distributors List
    Table 178. Equine Pharmaceuticals and Supplements Customers List
    Table 179. Equine Pharmaceuticals and Supplements Market Trends
    Table 180. Equine Pharmaceuticals and Supplements Market Drivers
    Table 181. Equine Pharmaceuticals and Supplements Market Challenges
    Table 182. Equine Pharmaceuticals and Supplements Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Equine Pharmaceuticals and Supplements Product Picture
    Figure 2. Global Equine Pharmaceuticals and Supplements Market Share by Type in 2020 & 2027
    Figure 3. Pharmaceuticals Product Picture
    Figure 4. Supplements Product Picture
    Figure 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020 & 2027
    Figure 6. Thoroughbred Horse
    Figure 7. Other Types of Horses
    Figure 8. Equine Pharmaceuticals and Supplements Report Years Considered
    Figure 9. Global Equine Pharmaceuticals and Supplements Sales 2016-2027 (K Units)
    Figure 10. Global Equine Pharmaceuticals and Supplements Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Equine Pharmaceuticals and Supplements Revenue 2016-2027 (US$ Million)
    Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 13. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2021)
    Figure 14. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2022-2027)
    Figure 15. North America Equine Pharmaceuticals and Supplements Sales YoY (2016-2027) & (K Units)
    Figure 16. North America Equine Pharmaceuticals and Supplements Revenue YoY (2016-2027) & (US$ Million)
    Figure 17. Europe Equine Pharmaceuticals and Supplements Sales YoY (2016-2027) & (K Units)
    Figure 18. Europe Equine Pharmaceuticals and Supplements Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Asia-Pacific Equine Pharmaceuticals and Supplements Sales YoY (2016-2027) & (K Units)
    Figure 20. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Latin America Equine Pharmaceuticals and Supplements Sales YoY (2016-2027) & (K Units)
    Figure 22. Latin America Equine Pharmaceuticals and Supplements Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Middle East & Africa Equine Pharmaceuticals and Supplements Sales YoY (2016-2027) & (K Units)
    Figure 24. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. The Top 10 and Top 5 Players Market Share by Equine Pharmaceuticals and Supplements Sales in 2020
    Figure 26. The Top 10 and Top 5 Players Market Share by Equine Pharmaceuticals and Supplements Revenue in 2020
    Figure 27. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 28. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 29. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 30. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 31. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 32. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 33. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 34. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 35. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 36. North America Equine Pharmaceuticals and Supplements Sales Share by Country (2016-2027)
    Figure 37. North America Equine Pharmaceuticals and Supplements Revenue Share by Country (2016-2027)
    Figure 38. U.S. Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 39. Canada Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 40. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 41. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 42. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 43. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 44. Europe Equine Pharmaceuticals and Supplements Sales Share by Country (2016-2027)
    Figure 45. Europe Equine Pharmaceuticals and Supplements Revenue Share by Country (2016-2027)
    Figure 46. Germany Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 47. France Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 48. U.K. Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 49. Italy Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 50. Russia Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 51. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 52. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 53. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 54. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 55. Asia Pacific Equine Pharmaceuticals and Supplements Sales Share by Region (2016-2027)
    Figure 56. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Share by Region (2016-2027)
    Figure 57. China Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 58. Japan Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 59. South Korea Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 60. India Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 61. Australia Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 62. Taiwan Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 63. Indonesia Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 64. Thailand Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 65. Malaysia Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 66. Philippines Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 67. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 68. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 69. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 70. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 71. Latin America Equine Pharmaceuticals and Supplements Sales Share by Country (2016-2027)
    Figure 72. Latin America Equine Pharmaceuticals and Supplements Revenue Share by Country (2016-2027)
    Figure 73. Mexico Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 74. Brazil Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 75. Argentina Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 76. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
    Figure 77. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
    Figure 78. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
    Figure 79. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
    Figure 80. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Share by Country (2016-2027)
    Figure 81. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Share by Country (2016-2027)
    Figure 82. Turkey Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 83. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 84. U.A.E Equine Pharmaceuticals and Supplements Revenue (2016-2027) & (US$ Million)
    Figure 85. Equine Pharmaceuticals and Supplements Value Chain
    Figure 86. Equine Pharmaceuticals and Supplements Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Frequently Asked Questions
Equine Pharmaceuticals and Supplements report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Equine Pharmaceuticals and Supplements report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Equine Pharmaceuticals and Supplements report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Portable Kayaks

The kayak has a rudder. During the competition, the athletes sit in the boat, facing forward, and ... Read More

Cat Litter Box

Market Analysis and Insights: Global Cat Litter Box Market
The global Cat Litter Bo ... Read More

Zero-Turn Mowers

A zero-turn riding Zero-Turn Mowers (colloquially, a z-turn) is a standard riding Zero-Turn Mower ... Read More